نتائج البحث

Application of signal processing techniques for the spectroscopic analysis of dolutegravir and lamivudine: a comparative assessment and greenness appraisal.

• Authors : Alnemari, Reem M.¹ (AUTHOR); Abdelazim, Ahmed H.² (AUTHOR); Almalki, Atiah H.^3,4 (AUTHOR)

• Source: BMC Chemistry. 7/8/2024, Vol. 18 Issue 1, p1-13. 13p.

تفاصيل العنوان

Efficacy and Safety of Switching to Dolutegravir/Lamivudine Versus Continuing a Tenofovir Alafenamide–Based Regimen in Virologically Suppressed Adults With Human Immunodeficiency Virus Type 1: Subgroup Analysis of Participants With Elvitegravir as Baseline Third Agent From the TANGO Study

• Authors : Ait-Khaled, Mounir¹ (AUTHOR); Oyee, James² (AUTHOR); Ooi, Adrian Yit Reen³ (AUTHOR)

• Source: Open Forum Infectious Diseases. May2024, Vol. 11 Issue 5, p1-4. 4p.

تفاصيل العنوان

Efficacy of Lamivudine Plus Dolutegravir vs Dolutegravir-Based 3-Drug Regimens in People With HIV Who Are Virologically Suppressed.

• Authors : Borghetti, Alberto¹ (AUTHOR) ; Ciccullo, Arturo² (AUTHOR); Lombardi, Francesca³ (AUTHOR)

• Source: Open Forum Infectious Diseases. May2024, Vol. 11 Issue 5, p1-6. 6p.

تفاصيل العنوان

Dolutegravir/Lamivudine Is Noninferior to Continuing Dolutegravir- and Non-Dolutegravir-Based Triple-Drug Antiretroviral Therapy in Virologically Suppressed People With Human Immunodeficiency Virus: DUALING Prospective Nationwide Matched Cohort Study.

• Authors : Vasylyev, Marta¹ (AUTHOR); Wit, Ferdinand W N M² (AUTHOR); Jordans, Carlijn C E¹ (AUTHOR)

• Source: Open Forum Infectious Diseases. Apr2024, Vol. 11 Issue 4, p1-10. 10p.

تفاصيل العنوان

Two-Drug Regimens Dolutegravir/Lamivudine and Dolutegravir/Rilpivirine Are Effective with Few Discontinuations in US Real-World Settings: Results from the TANDEM Study.

• Authors : Schneider, Stefan¹ (AUTHOR); Blick, Gary² (AUTHOR); Burke, Christina³ (AUTHOR)

• Source: Infectious Diseases & Therapy. Apr2024, Vol. 13 Issue 4, p891-906. 16p.

تفاصيل العنوان

High Prevalence of Hepatitis B Virus Drug Resistance Mutations to Lamivudine among People with HIV/HBV Coinfection in Rural and Peri-Urban Communities in Botswana.

• Authors : Phinius, Bonolo B.^1,2 (AUTHOR) ; Anderson, Motswedi¹ (AUTHOR) ; Gobe, Irene² (AUTHOR)

Subjects: *HEPATITIS B virus; *DISEASE prevalence; *LAMIVUDINEBOTSWANA

• Source: Viruses (1999-4915). Apr2024, Vol. 16 Issue 4, p592. 13p.

تفاصيل العنوان

DOLAMA 200: Effectiveness and Safety of a Dual Therapy with Dolutegravir Plus Lamivudine in Treatment-Experienced HIV-1 Infected Real World Participants in Spain.

• Authors : Sequera-Arquelladas, Sergio¹ (AUTHOR) ; Hidalgo-Tenorio, Carmen¹ (AUTHOR) ; López-Cortés, Luis² (AUTHOR)

Subjects: *LAMIVUDINE; *DOLUTEGRAVIR; *ATAZANAVIRSPAIN

• Source: Viruses (1999-4915). Feb2024, Vol. 16 Issue 2, p259. 13p.

تفاصيل العنوان

HIV-1 pretreatment and acquired antiretroviral drug resistance before tenofovir/ /lamivudine /dolutegravir (TLD) roll-out in Mozambique.

• Authors : Ismael N; Instituto Nacional de Saúde, EN1, Bairro da Vila - Parcela N˚3943, Marracuene Sede, Marracuene, Maputo Province, Mozambique. .; Division of Medical Virology, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa. .

Subjects: HIV Infections*/HIV Infections*/HIV Infections*/drug therapy ; HIV Infections*/HIV Infections*/HIV Infections*/virology ; Drug Resistance, Viral*/Drug Resistance, Viral*/Drug Resistance, Viral*/genetics

• Source: BMC infectious diseases [BMC Infect Dis] 2024 Jul 29; Vol. 24 (1), pp. 748. Date of Electronic Publication: 2024 Jul 29.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334

تفاصيل العنوان

Lamivudine and Entecavir for Acute Hepatitis B: A Systematic Review and Meta-Analysis.

• Authors : Henriquez-Camacho, Cesar¹ (AUTHOR) ; Hijas-Gomez, Ana Isabel² (AUTHOR); Risco Risco, Carlos³ (AUTHOR)

Subjects: *HEPATITIS B; *LAMIVUDINE; *VIRAL hepatitis

• Source: Viruses (1999-4915). Nov2023, Vol. 15 Issue 11, p2241. 13p.

تفاصيل العنوان

Lamivudine/Dolutegravir in Virologically Suppressed Subjects With Expected or Confirmed Resistance to Lamivudine (VOLVER)

• Authors : ViiV Healthcare

• Source: Virologic Outcomes of Lamivudine/Dolutegravir in Virologically Suppressed Subjects With Expected or Confirmed Resistance to Lamivudine.

تفاصيل العنوان